Acute Optic Neuritis Treatment Update Day

Are you a researcher, clinician, health care professional, or generally interested in the topic of neuroimmunological diseases?

The Acute Optic Neuritis Network is pleased to invite you to the Acute Optic Neuritis Treatment Update Day on May 5th 2023 in Tel Aviv, Israel. This will be a hybrid event. You can find more details here.

ACON is an international consortium, focused on studying diagnosis and treatment of subjects with a first-ever optic neuritis. The broad enrollment of patients of all ethnicities and from all continents ensures an excellent representation of the heterogeneity of this condition. Many of the enrolled patients will then be diagnosed with NMOSD, MOGAD or MS and are eligible for preventive immunotherapy.

The ACON offers an expert Treatment Day giving an overview of acute and long-term treatment Options in neuroimmunological diseases.

Debates, Talks, & Panel Discussions

Acute optic neuritis treatment
Long-term MOGAD and NMOSD treatment
Open discussion

Please find attached the program and register here.

Please share this invitation to anyone you think could be interested. If you have any questions, please do not hesitate to email susanna.asseyer@charite.de and kalishhadas@gmail.com.

January 19, 2023January 19, 2023

IMSVISUAL Symposium 2023

IMSVISUAL is holding its annual symposium in conjunction with the ACTRIMS Forum 2023 in San Diego, California on Saturday, February 25 from 12:30 – 1:30 PM PST. Please see the symposium schedule below. Click here to register for the ACTRIMS Forum 2023 and attend our session live.


12:30 - 12:35 PM	Introduction Shiv Saidha
12:35 - 12:50 PM	In Vivo Retinal Imaging in Translational Research Frederike Oertel
12:50 - 1:00 PM	Quantifying Retrograde Trans-Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis Sargis Manukyan
1:00 - 1:10 PM	Integration of MS Risk Genes with Single Cell Transcriptomics in the Retina and Predictors of Retinal Layer Thicknesses Samantha Hao
1:10 - 1:20 PM	Attractor-Like Changes in Dynamic Brain Connectivity Relate to Clinical Disability in Multiple Sclerosis Andrew Russo
1:20 - 1:30 PM	The Effects of Myelin Loss, Repair, and Remyelination Therapies on Visual Cortical Function Gustavo Della Flora Nunes

March 23, 2022March 23, 2022

IMSVISUAL Member Meeting – 2022

The IMSVISUAL Member Meeting was held virtually on Friday, March 4 from 10:00-11:00 am ET. To watch the member meeting, click below.

March 22, 2022January 19, 2023

IMSVISUAL Symposium 2022

IMSVISUAL held its annual symposium in conjunction with the ACTRIMS Forum 2022 in West Palm Beach, Florida on Friday, February 25 from 4:00-5:15 pm ET. Please see the symposium schedule below as well as the full recording from the session.


4:00pm-4:20pm	AP3.1 Optic Nerve MS Project Lucas Schirmer, Heidelberg University
4:20pm-4:40pm	AP3.2 Functional OCT Methods: Development and Application to NMO, Alzheimer’s, and MS David Bissig, UC Davis
4:40pm-4:50am	AP3.3 In vivo Modelling of Autoantibody-mediated Optic Neuritis Oliver Gramlich, Iowa City VA Health Care System
4:50pm-5:00pm	AP3.4 Characterization of Multiple Sclerosis Pathology in Retinal Ganglion Cells and Axonal Bundles by Adaptive Optics-Optical Coherence Tomography Katherine Kovalick, University of Maryland Medical Center
5:00pm-5:10pm	AP3.5 Deploying Machine Learning for Classification of Optic Neuritis Subtypes using Ocular Fundus Photographs as a Biomarker Etienne Benard-Seguin, University of Calgary
5:10pm-5:15pm	Q&A Discussion

January 28, 2021March 22, 2022

IMSVISUAL Member Meeting – 2021

February 24, 2021
10:30am – 12:00pm PST/ 12:30pm-2:00pm CST / 1:30-3:00pm EST / 6:30-8:00pm GMT / 7:30-9:00pm GMT+1

Please join us for the IMSVISUAL Member Meeting, taking place on February 24, 2021. An agenda for the meeting will be circulated to all registrants once finalized.

If you would like to attend the IMSVISUAL Member Meeting, please register for the meeting and suggest any agenda items through this survey.

January 22, 2021March 23, 2022

IMSVISUAL Symposium at the ACTRIMS Forum 2021

IMSVISUAL will hold a virtual symposium in conjunction with the ACTRIMS Forum 2021, which will take place virtually February 25-27, 2021. The IMSVISUAL Symposium is available to all registrants of the ACTRIMS Forum 2021

Symposium Chairs: E. Ann Yeh, The Hospital for Sick Children and Philipp Albrecht, University Hospital Düsseldorf

Six Months Results from the TONE Trial (Treatment of Optic Neuritis with Erythropoietin) in the Context of Visual Pathway Neuroprotection
Wolf Lagrèze, Universitätsklinikum Freiburg

Visual Outcome Metrics in MS: What are the Opportunities?
Heather Moss, Stanford University

Socioeconomic Disparity Correlates with Faster Inner Retinal Layer Thickness in Multiple Sclerosis
Elena Vasileiou, Johns Hopkins University School of Medicine

Identification of Optical Coherence Tomography Phenotypes and their Relationship with Patient Outcomes in Youth with Demyelinating Syndromes: Preliminary Results of an Unsupervised Machine Learning Analysis
Beyza Cifti-Kavakioglu, The Hospital for Sick Children

Neuroprotective Effects of the Sphingosine 1 Phosphate Receptor 1/5 Modulator RP-101074 on Retinal Neurodegeneration and Visual Function in Light-Induced Photoreceptor Loss
Christina Hecker, UKD

February 3, 2020February 3, 2020

Joint IMSVISUAL-NAIMS Symposium

Thursday, February 27, 2020, 11:15 am – 1:45 pm
Palm Beach County Convention Center, Grand Ballroom

This symposium is included in your ACTRIMS Forum 2020 registration. You must be registered for the Forum to attend this symposium.


Part 1: Chaired by Jiwon Oh, University of Toronto; Alex Brandt, Charité-Universitätsmedizin Berlin
11:15am-11:35am	Harmonizing Neuroimaging Data in Collaborative Networks Taki Shinohara, University of Pennsylvania
11:35am-11:50am	Visual Outcomes in Pediatric Demyelinating Disorders Ann Yeh, The Hospital for Sick Children
11:50am-12:05pm	Retinal Ganglion Cell Layer Thickness for Risk Stratification in Early Multiple Sclerosis Hanna Zimmermann, Charité-Universitätsmedizin Berlin
12:05pm-12:15pm	A New MRI Method for Visualizing Subpial Cortical Lesions at 3 Tesla Erin Beck, National Institute of Neurological Disorders and Stroke, National Institutes of Health
12:15pm-12:45pm	LUNCH
Part 2: Chaired by Shiv Saidha, Johns Hopkins University; Eric Klawiter, Massachusetts General Hospital
12:45pm-1:00pm	Genetic Predictors of Visual Dysfunction in People with Multiple Sclerosis Kathryn Fitzgerald, Johns Hopkins University
1:00pm-1:20pm	Imaging Correlates of Axonal Damage in MS Susie Huang, Massachusetts General Hospital, Harvard Medical School
1:20pm-1:35pm	VISIONARY-MS: A Phase 2 clinical trial of catalytic gold nanocrystals, CNM-Au8, for the treatment of chronic optic neuropathy Robert Glanzman, Clene Nanomedicine, Inc.
1:35pm-1:45pm	Functional Connectivity Predicts MS Patients' Impairment Using An Ensemble Model Applied With A Machine Learning Approach Ceren Tozlu, Weill Cornell Medicine

September 20, 2019February 3, 2020

Save the Date – IMSVISUAL Events at the ACTRIMS Forum

Please save the date for the following IMSVISUAL Events, taking place in conjunction with the ACTRIMS Forum 2020 in West Palm Beach, February 27-29, 2020.

IMSVISUAL Member Meeting: 7:30-9:00am, Thursday, February 27
Joint NAIMS-IMSVISUAL Symposium: 11:15am-1:45pm, Thursday, February 27

August 13, 2019August 26, 2019

2019 ECTRIMS Meeting of IMSVISUAL

IMSVISUAL Meeting

Thursday, September 12, 2019, 17:00
Meeting Room B9, Stockholmsmässan
ECTRIMS Congress Venue

Preliminary Programme

17:00	Welcome and Proceedings F. Paul, Berlin
17:15	Results of the OCTIMS study F. Paul, Berlin
17:30	OCT in experimental MS models P. Albrecht, Düsseldorf
17:45	Vision investigator race 4 brief presentations by junior researchers TBD
18:45	Miscellaneous and Farewell
19:00	End

Snacks and beverages will be provided.

Registration

The number of participants is limited to 50 pax. Please RSVP until September 5th, 2019, by using the online registration form.

January 10, 2019August 26, 2019

IMSVISUAL Symposium at ACTRIMS Forum 2019

It is our pleasure to invite you to our IMSVISUAL symposium at ACTRIMS Forum 2019 (being held in Dallas, Texas, February 28 – March 2), to discuss updates on vision research in multiple sclerosis and related disorders. For the third consecutive year we are fortunate to have secured ACTRIMS as our sponsor.

The symposium, integrated into the ACTRIMS program and CME accredited, will take place on Thursday, February 28th from 12:30pm – 1:45pm. Please see below the confirmed agenda for talks/speakers during the session. This symposium/session is open to all attendees of the ACTRIMS Forum 2019.

I think this will be an exciting symposium with presentations from
several groups representing existing IMSVISUAL member sites from
around the world.

We look forward to seeing you all in Dallas!

IMSVISUAL symposium at the ACTRIMS Forum 2019, Thursday, February 28th

Session Chairs: Laura Balcer, NYU Langone Health and Elena Martínez-Laspiscina, Hospital Clínic de Barcelona

Symposium Schedule

1: “Is there progressive retinal damage in neuromyelitis optica spectrum disorders?”
Friedemann Paul, NeuroCure Clinical Research Center

2: “Smartphone Suite of Visual Tests in Multiple Sclerosis”
Randy Kardon, University of Iowa Health Care

3: “Corneal Confocal Microscopy: “A rapid non-invasive technique to image neurodegeneration”
Ioannis Petropoulos, Weill Cornell Medicine – Qatar

4: “Dynamics of retinal layer atrophy in normal aging and multiple sclerosis”
Elias Sotirchos, Johns Hopkins University

5: “Retinal imaging in EAE for translational neuroprotection studies”
Philipp Albrecht, Heinrich-Heine-Universität Düsseldorf